Advancing treatments for rare diseases together

Rimeporide in Duchenne presented at the ICNMD XIII congress

05Jul

EspeRare presented the “Development of Rimeporide, a selective sodium-hydrogen exchanger inhibitor, for Patient with Duchenne Muscular Dystrophy”  at the 13th International Congress on Neuromuscular Diseases in Nice from the 5-10th of July 2014.

Development of Rimeporide, a selective sodium-hydrogen exchanger inhibitor (NHE-1), for Patient for Duchenne Muscular Dystrophy
Click on picture to view

For more information on the ICNMD congress click here